Documentos relacionados

1. Tacrolimus for Treating Orbital and Cranial Form of Idiopathic Inflammatory Pseudotumors.
2. Destabilisation of T cell-dependent humoral immunity in sepsis.
3. Preventative effect of TSPO ligands on mixed antibody-mediated rejection through a Mitochondria-mediated metabolic disorder.
4. The effects of targeted immune-regulatory strategies on tumor-specific T-cell responses in vitro.
5. Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche.
6. Activated B cells suppress T-cell function through metabolic competition.
7. Intralesional corticosteroids and diathermy ablation for the management of anogenital granulomatosis: a retrospective cohort study.
8. Cladribine Effects on T and B Cells and T Cell Reactivity in Multiple Sclerosis.
9. Long-term results of topical 0.02% tacrolimus ointment for refractory ocular surface inflammation in pediatric patients.
10. Nuclear factor of activated T cells as potential pharmacodynamic biomarker for the risk of acute and subclinical rejection in de novo liver recipients.